Condition: Pancreatic Cancer · Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
This study is designed to investigate the safety of intraoperative radiation therapy (IORT) in patients with localized pancreatic cancer undergoing surgical resection after neoadjuvant chemotherapy and stereotactic body radiation therapy (SBRT).
This description comes directly from the study's public registry record.
Amol Narang, MD · 410-502-3828 · anarang2@jh.edu
Dana B Kaplin, MPH · 410-502-3950 · dkaplin1@jhmi.edu
Always discuss trial participation with your own doctor first.
| Johns Hopkins Hospital | Baltimore, Maryland, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05141513